Skip to content
Tenfell
Awarded contract
Published 07 Jun 2021

NHS National Generic Pharmaceuticals - Transition 2021_2

NHS England · London

Key facts

Awarded
31 Mar 2021
Contract starts
14 Jun 2021
Contract ends
31 Jan 2023
Procedure
Open procedure (below threshold)
Buyer type
Central government

Awarded to 17 suppliers

SupplierValue
Dr Reddy's Laboratories (UK) Ltd—
Ranbaxy (UK) Ltd—
Selective Supplies Ltd—
Thornton & Ross Ltd—
Accord-UK Ltd—
Neon Healthcare Ltd—
Amarox Limited—
Brown & Burk UK Ltd—
Day Lewis Medical Ltd—
Milpharm Ltd/aurobinbdo—
Aspire Pharma Ltd—
Lexon Uk Ltd—
Laboratorio Reig Jofre SA—
Morningside Pharmaeuticals—
Waverley Pharma Europe Limited—
Bristol Laboratories Limited—
Cipla (EU) Ltd—

Description

Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)

Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months)

Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.